Viewing Study NCT00060203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-02-20 @ 5:57 PM
Study NCT ID: NCT00060203
Status: COMPLETED
Last Update Posted: 2014-01-16
First Post: 2003-05-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
Sponsor: Case Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma and Plasma Cell Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III multiple myeloma View
None refractory multiple myeloma View